In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Health and Human Services Secretary Robert F. Kennedy Jr. faced a fiery Senate showdown as lawmakers grilled him over vaccine ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...